Detail Information of Transcriptional Regulations

General Information of Drug Transporter (DT)
DT ID DTD0029 Transporter Info
Gene Name SLCO1A2
Transporter Name Organic anion transporting polypeptide 1A2
Gene ID
6579
UniProt ID
P46721

Transcriptional Regulation of This DT (TSR)

TF Superclass 2: Zinc-coordinating DNA-binding domains

      Class 2.1: Nuclear receptors with C4 zinc fingers

Click to Show/Hide the Full List of 2 TF(s) Regulating This DT

        NR1I2 

Click to Show/Hide to Show 2 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Activation of SLCO1A2 gene in breast cancer condition [1]

TF Protein Name

 Nuclear receptor subfamily 1 group I member 2 Transcription Factor Info

Studied Phenotype

 Breast cancer [ICD11: 2C60-2C6Z]

Tissue

 Breast

Related DT Changes

 Up regulating

Experimental Material

 human breast cancer cell isolates

Detailed Description

 Nuclear receptor subfamily 1 group I member 2 (NR1I2) has been reported to activate the transcription of SLCO1A2 gene in breast cancer condition, which leads to an increased expression of the drug transporter Organic anion transporting polypeptide 1A2.

       Transcriptional Phenomenon 2

 Activation of SLCO1A2 gene in health condition [2]

TF Protein Name

 Nuclear receptor subfamily 1 group I member 2 Transcription Factor Info

Studied Phenotype

 Heallth [ICD11: N.A]

Tissue

 Liver

Related DT Changes

 up regulating

Experimental Material

 Human liver samples

Detailed Description

 Nuclear receptor subfamily 1 group I member 2 (NR1I2), influenced by the metabolite from Host unspecified microbiota, has been reported to activate the transcription of SLCO1A2 gene in health condition, which leads to an increased expression of the drug transporter Organic anion transporting polypeptide 1A2.

        VDR 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Activation of SLCO1A2 gene in colon cancer condition [3]

TF Protein Name

 Vitamin D3 receptor Transcription Factor Info

Studied Phenotype

 Colon cancer [ICD11: 2B90]

Tissue

 Colon

Related DT Changes

 Up regulating

Experimental Material

 Human colon adenocarcinoma cells (Caco-2)

Detailed Description

 Vitamin D3 receptor (VDR) has been reported to activate the transcription of SLCO1A2 gene in colon cancer condition, which leads to an increased expression of the drug transporter Organic anion transporting polypeptide 1A2.

TF Superclass 6: Immunoglobulin fold

      Class 6.1: Rel homology region factors

Click to Show/Hide the Full List of 2 TF(s) Regulating This DT

        NFKB1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Repression of SLCO1A2 gene in breast cancer condition [4]

TF Protein Name

 Nuclear factor NF-kappa-B p105 subunit Transcription Factor Info

Studied Phenotype

 Breast cancer [ICD11: 2C60-2C6Z]

Tissue

 Breast

Related DT Changes

 Down regulating

Experimental Material

 Human invasive breast carcinoma of no special type cells (MCF-7)

Detailed Description

 Nuclear factor NF-kappa-B p105 subunit (NFKB1) has been reported to repress the transcription of SLCO1A2 gene in breast cancer condition, which leads to a decreased expression of the drug transporter Organic anion transporting polypeptide 1A2.

        RELA 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Repression of SLCO1A2 gene in breast cancer condition [4]

TF Protein Name

 Transcription factor p65 Transcription Factor Info

Studied Phenotype

 Breast cancer [ICD11: 2C60-2C6Z]

Tissue

 Breast

Related DT Changes

 Down regulating

Experimental Material

 Human invasive breast carcinoma of no special type cells (MCF-7)

Detailed Description

 Transcription factor p65 (RELA) has been reported to repress the transcription of SLCO1A2 gene in breast cancer condition, which leads to a decreased expression of the drug transporter Organic anion transporting polypeptide 1A2.
References
1 Interplay between the nuclear receptor pregnane X receptor and the uptake transporter organic anion transporter polypeptide 1A2 selectively enhances estrogen effects in breast cancer. Cancer Res. 2008 Nov 15;68(22):9338-47.
2 Transcriptional profiling of genes induced in the livers of patients treated with carbamazepine. Clin Pharmacol Ther. 2006 Nov;80(5):440-456.
3 The SLCO1A2 gene, encoding human organic anion-transporting polypeptide 1A2, is transactivated by the vitamin D receptor. Mol Pharmacol. 2012 Jul;82(1):37-46.
4 Identification of a NF Kappa B Inhibition Site on the Proximal Promoter Region of Human Organic Anion Transporting Polypeptide 1A2 Coding Gene SLCO1A2. Drug Metab Dispos. 2018 May;46(5):643-651.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.